GMP production of anti-tumor cytotoxic T-cell lines for adoptive T-cell therapy in patients with solid neoplasia

I Turin Immunology Laboratory and Pediatric Hematology/Oncology, IRCCS Policlinico San Matteo, Milan, Italy

P Pedrazzoli Falck Division of Medical Oncology, Ospedale Niguarda Ca’ Granda, Milan, Italy

C Tullio Falck Division of Medical Oncology, Ospedale Niguarda Ca’ Granda, Milan, Italy

E Montini Immunology Laboratory and Pediatric Hematology/Oncology, IRCCS Policlinico San Matteo, Milan, Italy

M Carmela La Grotteria Falck Division of Medical Oncology, Ospedale Niguarda Ca’ Granda, Milan, Italy

R Schiavo Falck Division of Medical Oncology, Ospedale Niguarda Ca’ Granda, Milan, Italy

C Perotti Immunohaematology and Transfusion Service, IRCCS Policlinico San Matteo, Pavia, Italy

F Locatelli Immunology Laboratory and Pediatric Hematology/Oncology, IRCCS Policlinico San Matteo, Milan, Italy; Department of Pediatrics, University of Pavia, Pavia, Italy

E Carretto Laboratory of Experimental Research, Area Infettivologica, IRCCS Policlinico San Matteo, Pavia, Italy

R Maccario Immunology Laboratory and Pediatric Hematology/Oncology, IRCCS Policlinico San Matteo, Milan, Italy

S Siena Falck Division of Medical Oncology, Ospedale Niguarda Ca’ Granda, Milan, Italy

D Montagna Immunology Laboratory and Pediatric Hematology/Oncology, IRCCS Policlinico San Matteo, Milan, Italy; Department of Pediatrics, University of Pavia, Pavia, ItalyCorrespondence[email protected].

show all

Citations (2)

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Claudia Rossig. (2012) Anti-tumor cytotoxic T lymphocytes targeting solid tumors: Ready for clinical trials. Cytotherapy 14:1, pages 4-6.
Read now

Daniela Montagna, Ilaria Turin, Roberta Schiavo, Enrica Montini, Nadia Zaffaroni, Raffaella Villa, Simona Secondino, Ilaria Schiavetto, Laura Caliogna, Franco Locatelli, Virginia Libri, Andrea Pession, Roberto Tonelli, Rita Maccario, Salvatore Siena & Paolo Pedrazzoli. (2012) Feasibility and safety of adoptive immunotherapy with ex vivo-generated autologous, cytotoxic T lymphocytes in patients with solid tumor. Cytotherapy 14:1, pages 80-90.
Read now

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

GMP production of anti-tumor cytotoxic T-cell lines for adoptive T-cell therapy in patients with solid neoplasia

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

GMP production of anti-tumor cytotoxic T-cell lines for adoptive T-cell therapy in patients with solid neoplasia

Citations (2)

Read on this site (2)

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date